Literature DB >> 20675133

SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.

Donghong Amy Gao1, Zhaoming Xiong, Alexander Heim-Riether, Laura Amodeo, E Michael August, Xianhua Cao, Leonard Ciccarelli, Brandon K Collins, Kyle Harrington, Kathleen Haverty, Melissa Hill-Drzewi, Xiang Li, Shuang Liang, Steluta Mariana Margarit, Neil Moss, Nelamangala Nagaraja, John Proudfoot, Rene Roman, Sabine Schlyer, Lana Smith Keenan, Steven Taylor, Bernd Wellenzohn, Dieter Wiedenmayer, Jun Li, Neil A Farrow.   

Abstract

SAR studies to improve the selectivity and metabolic stability of a class of recently discovered MMP-13 inhibitors are reported. Improved selectivity was achieved by modifying interactions with the S1' pocket. Metabolic stability was improved through reduction of inhibitor lipophilicity. This translated into lower in vivo clearance for the preferred compound. Copyright 2010 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20675133     DOI: 10.1016/j.bmcl.2010.07.036

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.

Authors:  Joshua Roth; Dmitriy Minond; Etzer Darout; Qin Liu; Janelle Lauer; Peter Hodder; Gregg B Fields; William R Roush
Journal:  Bioorg Med Chem Lett       Date:  2011-09-22       Impact factor: 2.823

Review 2.  The history of matrix metalloproteinases: milestones, myths, and misperceptions.

Authors:  Rugmani Padmanabhan Iyer; Nicolle L Patterson; Gregg B Fields; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

3.  Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins.

Authors:  Laurent Devel; Fabrice Beau; Mehdi Amoura; Laura Vera; Evelyne Cassar-Lajeunesse; Sandra Garcia; Bertrand Czarny; Enrico A Stura; Vincent Dive
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

4.  Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases.

Authors:  Manishabrata Bhowmick; Dorota Tokmina-Roszyk; Lillian Onwuha-Ekpete; Kelli Harmon; Trista Robichaud; Rita Fuerst; Roma Stawikowska; Bjorn Steffensen; William Roush; Hector R Wong; Gregg B Fields
Journal:  J Med Chem       Date:  2017-04-19       Impact factor: 7.446

5.  Matrix Metalloproteinase 13 Inhibitors for Modulation of Osteoclastogenesis: Enhancement of Solubility and Stability.

Authors:  Anna M Knapinska; Chandani Singh; Gary Drotleff; Daniela Blanco; Cedric Chai; Jason Schwab; Anu Herd; Gregg B Fields
Journal:  ChemMedChem       Date:  2021-01-26       Impact factor: 3.466

Review 6.  New strategies for targeting matrix metalloproteinases.

Authors:  Gregg B Fields
Journal:  Matrix Biol       Date:  2015-01-14       Impact factor: 11.583

7.  Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.

Authors:  Timothy P Spicer; Jianwen Jiang; Alexander B Taylor; Jun Yong Choi; P John Hart; William R Roush; Gregg B Fields; Peter S Hodder; Dmitriy Minond
Journal:  J Med Chem       Date:  2014-11-11       Impact factor: 7.446

Review 8.  Regulation and involvement of matrix metalloproteinases in vascular diseases.

Authors:  Matthew Amin; Sathnur Pushpakumar; Nino Muradashvili; Sourav Kundu; Suresh C Tyagi; Utpal Sen
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01-01

9.  Indole Inhibitors of MMP-13 for Arthritic Disorders.

Authors:  Steven J Taylor; Asitha Abeywardane; Shuang Liang; Zhaoming Xiong; John R Proudfoot; Bennett Sandy Farmer; Donghong A Gao; Alexander Heim-Riether; Lana Louise Smith-Keenan; Ingo Muegge; Yang Yu; Qiang Zhang; Donald Souza; Mark Panzenbeck; Daniel Goldberg; Melissa Hill-Drzewi; Mariana Margarit; Brandon Collins; John Xiang Li; Ljiljana Zuvela-Jelaska; Jun Li; Neil A Farrow
Journal:  ACS Omega       Date:  2021-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.